Brief: Targovax Releases Update For Mesothelioma Trial Combining ONCOS-102 And Chemotherapy
May 4 (Reuters) - Targovax ASA TRVX.OL :
* TARGOVAX RELEASES UPDATE FOR MESOTHELIOMA TRIAL COMBINING
ONCOS-102 AND CHEMOTHERAPY
* IMMUNE ACTIVATION IS FURTHER VALIDATED IN ONCOS-102
TREATED
GROUP
* FIRST LINE MESOTHELIOMA REMAINS FOCUS FOR NEXT PHASE OF
DEVELOPMENT
Source text for Eikon: ID:nWkrb5HT2N
Further company coverage: TRVX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Circio Holding ASA
See all newsBrief: Circio, Genassist Jointly Announce Gene Therapy Research Collaboration
Brief: Circio And Aavigen To Collaborate On In Heart Gene Therapy
Brief: Circio Commences Exercise Period For Warrants
Brief: Circio Holding Files New Circvec Patent Application
Brief: Circio, Traffikgene Enter Research Collaboration